Concepedia
Statistics
Publications
16
Citations
551
H-Index
14
Active since
2009
Affiliations
Asan Medical Center(Current)
University of Ulsan
Ulsan College
Korea Research Institute of Chemical Technology
National Cancer Institute
Kang‐Seo Park is an author at Asan Medical Center specializing in oncology, molecular oncology, and medicine.
Publications per year
2009–2021
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
Kang‐Seo Park, Hyun‐Kyoung Kim, Jung-Hwa Lee et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 108 citations · Full text
Medicine, Oncology, Pharmacology +14
Differences in the molecular signatures of mucosal-associated invariant T cells and conventional T cells
Daeui Park, Hong Gi Kim, Mi‐Ok Kim et al. · Scientific Reports · 2019 · 48 citations · Full text
Life Sciences, Immunology, Molecular Biology +15
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib
Kang‐Seo Park, Bora Oh, Mi-Hee Lee et al. · Cancer Letters · 2015 · 41 citations
Medicine, Oncology, Pharmacology +15
Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes
Sangsu Shin, Mi‐Ok Kim, Seon‐Jin Lee et al. · Cancer Genomics & Proteomics · 2017 · 40 citations · Full text
Medicine, Oncology, Pharmacology +17
Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.
Junyoung Choi, Hee Jin Lee, Shinkyo Yoon et al. · PubMed · 2020 · 36 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 16